Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Discovery and characterization of atropisomer PH-797804, a p38 MAP kinase inhibitor, as a clinical drug candidate.

Xing L, Devadas B, Devraj RV, Selness SR, Shieh H, Walker JK, Mao M, Messing D, Samas B, Yang JZ, Anderson GD, Webb EG, Monahan JB.

ChemMedChem. 2012 Feb 6;7(2):273-80. doi: 10.1002/cmdc.201100439. Epub 2011 Dec 15.

PMID:
22174080
2.

Stability in the composition equivalence of grain from insect-protected maize and seed from glyphosate-tolerant soybean to conventional counterparts over multiple seasons, locations, and breeding germplasms.

Zhou J, Harrigan GG, Berman KH, Webb EG, Klusmeyer TH, Nemeth MA.

J Agric Food Chem. 2011 Aug 24;59(16):8822-8. doi: 10.1021/jf2019038. Epub 2011 Jul 28.

PMID:
21797257
3.

Substituted N-aryl-6-pyrimidinones: a new class of potent, selective, and orally active p38 MAP kinase inhibitors.

Devadas B, Selness SR, Xing L, Madsen HM, Marrufo LD, Shieh H, Messing DM, Yang JZ, Morgan HM, Anderson GD, Webb EG, Zhang J, Devraj RV, Monahan JB.

Bioorg Med Chem Lett. 2011 Jul 1;21(13):3856-60. doi: 10.1016/j.bmcl.2011.05.006. Epub 2011 May 8.

PMID:
21620699
4.

The antagonists but not partial agonists of glucocorticoid receptor ligands show substantial side effect dissociation.

Hu X, Du S, Tunca C, Braden T, Long KR, Lee J, Webb EG, Dietz JD, Hummert S, Rouw S, Hegde SG, Webber RK, Obukowicz MG.

Endocrinology. 2011 Aug;152(8):3123-34. doi: 10.1210/en.2010-1447. Epub 2011 May 10.

PMID:
21558312
5.

A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation.

Mourey RJ, Burnette BL, Brustkern SJ, Daniels JS, Hirsch JL, Hood WF, Meyers MJ, Mnich SJ, Pierce BS, Saabye MJ, Schindler JF, South SA, Webb EG, Zhang J, Anderson DR.

J Pharmacol Exp Ther. 2010 Jun;333(3):797-807. doi: 10.1124/jpet.110.166173. Epub 2010 Mar 17.

PMID:
20237073
6.

Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.

Hope HR, Anderson GD, Burnette BL, Compton RP, Devraj RV, Hirsch JL, Keith RH, Li X, Mbalaviele G, Messing DM, Saabye MJ, Schindler JF, Selness SR, Stillwell LI, Webb EG, Zhang J, Monahan JB.

J Pharmacol Exp Ther. 2009 Dec;331(3):882-95. doi: 10.1124/jpet.109.158329. Epub 2009 Aug 31.

PMID:
19720877
7.

Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment.

Gerstenfeld LC, Al-Ghawas M, Alkhiary YM, Cullinane DM, Krall EA, Fitch JL, Webb EG, Thiede MA, Einhorn TA.

J Bone Joint Surg Am. 2007 Jan;89(1):114-25.

PMID:
17200318
8.

Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents.

Achilefu S, Jimenez HN, Dorshow RB, Bugaj JE, Webb EG, Wilhelm RR, Rajagopalan R, Johler J, Erion JL.

J Med Chem. 2002 May 9;45(10):2003-15.

PMID:
11985468
9.

Preparation, characterization, and biological evaluation of technetium(V) and rhenium(V) complexes of novel heterocyclic tetradentate N3S ligands.

Rajagopalan R, Grummon GD, Bugaj J, Hallemann LS, Webb EG, Marmion ME, Vanderheyden JL, Srinivasan A.

Bioconjug Chem. 1997 May-Jun;8(3):407-15.

PMID:
9177848
10.

A Case of Intrathoracic Lipoma.

Abbott AC, Webb EG.

Can Med Assoc J. 1935 Dec;33(6):660-1. No abstract available.

Supplemental Content

Support Center